Determinants of protein function revealed by combinatorial entropy optimization

Por Reva, Boris, Antipin, Yevgeniy, Sander, Chris
Publicado em 2007

Predicting the functional impact of protein mutations: application to cancer genomics

Por Reva, Boris, Antipin, Yevgeniy, Sander, Chris
Publicado em 2011

Strand-specific in vivo screen of cancer-associated miRNAs unveils a role for miR-21(*) in SCC progression

Por Ge, Yejing, Zhang, Liang, Nikolova, Maria, Reva, Boris, Fuchs, Elaine
Publicado no Nat Cell Biol (2015)

A new molecular signature method for prediction of driver cancer pathways from transcriptional data

Por Rykunov, Dmitry, Beckmann, Noam D., Li, Hui, Uzilov, Andrew, Schadt, Eric E., Reva, Boris
Publicado no Nucleic Acids Res (2016)

Unsuspected collision of synchronous lung adenocarcinomas: a potential cause of aberrant driver mutation profiles

Por Rekhtman, Natasha, Borsu, Laetitia, Reva, Boris, Arcila, Maria, Riely, Gregory J., Ladanyi, Marc, Drilon, Alexander
Publicado em 2014

Direct in Vivo RNAi Screen Unveils Myosin IIa as a Tumor Suppressor of Squamous Cell Carcinomas

Por Schramek, Daniel, Sendoel, Ataman, Segal, Jeremy P., Beronja, Slobodan, Heller, Evan, Oristian, Daniel, Reva, Boris, Fuchs, Elaine
Publicado em 2014

The molecular diversity of Luminal A breast tumors

Por Ciriello, Giovanni, Sinha, Rileen, Hoadley, Katherine A., Jacobsen, Anders S., Reva, Boris, Perou, Charles M., Sander, Chris, Schultz, Nikolaus
Publicado em 2013

Clinical and in vivo Evidence that EGFR S768I Mutant Lung Adenocarcinomas Are Sensitive to Erlotinib

Por Hellmann, Matthew D., Reva, Boris, Yu, Helena, Rusch, Valerie W, Rizvi, Naiyer A, Kris, Mark G, Arcila, Maria E
Publicado no J Thorac Oncol (2014)

EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics

Por Arcila, Maria E, Nafa, Khedoudja, Chaft, Jamie E, Rekhtman, Natasha, Lau, Christopher, Reva, Boris A, Zakowski, Maureen F, Kris, Mark G, Ladanyi, Marc
Publicado em 2013

MAP2K1 (MEK1) mutations define a distinct subset of lung adenocarcinoma associated with smoking

Por Arcila, Maria E., Drilon, Alexander, Sylvester, Brooke E., Lovly, Christine M., Borsu, Laetitia, Reva, Boris, Kris, Mark G., Solit, David B., Ladanyi, Marc
Publicado no Clin Cancer Res (2014)

Mutation Screening of Candidate Genes in Patients with Nonsyndromic Sagittal Craniosynostosis

Por Ye, Xiaoqian, Guilmatre, Audrey, Reva, Boris, Peter, Inga, Heuzé, Yann, Richtsmeier, Joan T., Fox, Deborah J., Goedken, Rhinda J., Jabs, Ethylin W, Romitti, Paul A.
Publicado no Plast Reconstr Surg (2016)

Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells

Por Asai, Takashi, Liu, Yan, Di Giandomenico, Silvana, Bae, Narae, Ndiaye-Lobry, Delphine, Deblasio, Anthony, Menendez, Silvia, Antipin, Yevgeniy, Reva, Boris, Wevrick, Rachel, Nimer, Stephen D.
Publicado em 2012

Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma

Por Cotignola, Javier, Reva, Boris, Mitra, Nandita, Ishill, Nicole, Chuai, Shaokun, Patel, Ami, Shah, Shivang, Vanderbeek, Gretchen, Coit, Daniel, Busam, Klaus, Halpern, Allan, Houghton, Alan, Sander, Chris, Berwick, Marianne, Orlow, Irene
Publicado em 2007

p53 Regulates Hematopoietic Stem Cell Quiescence

Por Liu, Yan, Elf, Shannon E., Miyata, Yasuhiko, Sashida, Goro, Liu, Yuhui, Huang, Gang, Giandomenico, Silvana Di, Lee, Jennifer M., Deblasio, Anthony, Menendez, Silvia, Antipin, Jack, Reva, Boris, Koff, Andrew, Nimer, Stephen D.
Publicado em 2009

Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif

Por Hamilton, Mark P., Rajapakshe, Kimal, Hartig, Sean M., Reva, Boris, McLellan, Michael D., Kandoth, Cyriac, Ding, Li, Zack, Travis I., Gunaratne, Preethi H., Wheeler, David A., Coarfa, Cristian, McGuire, Sean E.
Publicado em 2013

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Por Cerami1, Ethan, Gao, Jianjiong, Dogrusoz, Ugur, Gross, Benjamin E., Sumer, Selcuk Onur, Aksoy, Bülent Arman, Jacobsen, Anders, Byrne, Caitlin J., Heuer, Michael L., Larsson, Erik, Antipin, Yevgeniy, Reva, Boris, Goldberg, Arthur P., Sander, Chris, Schultz, Nikolaus
Publicado em 2012

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

Por Bott, Matthew, Brevet, Marie, Taylor, Barry S, Shimizu, Shigeki, Ito, Tatsuo, Wang, Lu, Creaney, Jenette, Lake, Richard A, Zakowski, Maureen F, Reva, Boris, Sander, Chris, Delsite, Robert, Powell, Simon, Zhou, Qin, Shen, Ronglai, Olshen, Adam, Rusch, Valerie, Ladanyi, Marc
Publicado no Nat Genet (2011)

Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: a Report by MSKCC and the KIRC TCGA Research Network

Por Hakimi, A Ari, Ostrovnaya, Irina, Reva, Boris, Schultz, Nikolaus, Chen, Ying-Bei, Gonen, Mithat, Liu, Han, Takeda, Shugaku, Voss, Martin H, Tickoo, Satish K, Reuter, Victor E, Russo, Paul, Cheng, Emily H., Sander, Chris, Motzer, Robert J., Hsieh, James J.
Publicado em 2013

Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer...

Por Nair, Navya, Camacho-Vanegas, Olga, Rykunov, Dmitry, Dashkoff, Matthew, Camacho, Sandra Catalina, Schumacher, Cassie A., Irish, Jonathan C., Harkins, Timothy T., Freeman, Elijah, Garcia, Isaac, Pereira, Elena, Kendall, Sviatoslav, Belfer, Rachel, Kalir, Tamara, Sebra, Robert, Reva, Boris, Dottino, Peter, Martignetti, John A.
Publicado no PLoS Med (2016)

A Specificity Map for the PDZ Domain Family

Por Tonikian, Raffi, Zhang, Yingnan, Sazinsky, Stephen L, Currell, Bridget, Yeh, Jung-Hua, Reva, Boris, Held, Heike A, Appleton, Brent A, Evangelista, Marie, Wu, Yan, Xin, Xiaofeng, Chan, Andrew C, Seshagiri, Somasekar, Lasky, Laurence A, Sander, Chris, Boone, Charles, Bader, Gary D, Sidhu, Sachdev S
Publicado em 2008